Published in Obesity and Diabetes Week, September 12th, 2005
In a recently published article, scientists in Israel conducted a study "To compare the efficacy of insulin pump treatment with multiple daily injections in the treatment of poorly controlled obese type 2 diabetic patients already receiving two or more daily injections of insulin plus metformin. Forty obese type 2 diabetic subjects (using insulin) were randomized to treatment with continuous subcutaneous infusion pump (CSII) (Minimed) or multiple daily insulin injections (MDI)."
"At the end of the first 18-week treatment...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week